Clinical and economic burden of chemotherapy-induced nausea and vomiting among patients with cancer in a hospital outpatient setting in the United States.

Journal of medical economics

Volumn 14, Issue 1, 2011, Pages 87-98

  Craver, Chris ^a   Gayle, Julie ^b   Balu, Sanjeev ^b   Buchner, Deborah ^b  

^a Premier Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; COST OF ILLNESS; ECONOMICS; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NAUSEA; NEOPLASM; OUTPATIENT DEPARTMENT; RETROSPECTIVE STUDY; UNITED STATES; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC AGENTS; COST OF ILLNESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; UNITED STATES; VOMITING;

EID: 79957637306     PISSN: None     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2010.547237     Document Type: Article

References (0)